Background: Current guidelines for screening of colorectal cancer do not offer specific recommendations for cessation of antithrombotic agents prior to fecal occult blood test (FOBT). Aim ...

A groundbreaking blood test for colorectal cancer screening could reshape early detection. Learn how this FDA-approved method ...

Discover how the FIT test is transforming colorectal cancer screening, reducing mortality rates and offering a more ...

Regular fecal occult blood test (FOBT) screening for colorectal cancer is cost-effective in the general population, yet data are limited regarding the cost-effectiveness of FOBT screening in renal ...

5. Colorectal Cancer Screening Women should begin screening at age 45. Options include fecal occult blood tests, fecal immunochemical tests, or a colonoscopy. Starting at age 35, especially if you ...

The usual Part B deductible is waived for these tests. Colorectal Annual fecal occult blood test for those older than 50 years of age. Flexible sigmoidoscopy every 4 years for those older than 50 ...

Sysmex America, Inc., a leading diagnostic solutions company offering hematology, hemostasis, urinalysis, flow cytometry and ...

The company hopes that its noninvasive assay is easier to use than stool-based fecal occult blood tests (FOBTs), currently the mainstay for early detection, but it does not see it replacing ...

When patients of the Harris Health System have a positive FIT result, they are referred to a gastroenterologist for a colonoscopy. To help patients understand how to properly prepare for the procedure ...

Under the agreement, Sysmex will distribute and service in Canada Sentinel Diagnostics' SentiFit 270 and SentiFit 800 analyzers for fecal immunochemical testing.

The SENTiFIT 800 Analyzer by Sentinel Diagnostics is a high-speed system for CRC screening organizations and laboratories with a high volume of fecal occult blood and calprotectin tests.